Text Size: a  |   a 

Vitamin D Levels Seen to Only Predict Relapse Rates in Younger MS Patients

June 27, 2016

While it has been researched that low levels of Vitamin D are linked to multiple sclerosis, a new study has used real-life, clinical data from a large group of MS patients that found no relationship between the lack of vitamin and disability progression in MS patients. Scientists are still uncertain of how exactly disability progression is found to correlate with vitamin D levels.

A retrospective three-year follow up study that involved 554 MS patients was conducted and determined the effect of Vitamin D status on relapse rate, disability, and disability progression. This was determined using EDSS, the Expanded Disability Status Scale.

Researchers determined that Vitamin D had no effect on disease disability, which was expressed by EDSS, or on the accumulation of disability over time. On the other hand, they did observe a strong trend for the vitamin levels predicting the occurrence of relapses. This was only detected in the youngest MS patients.

These results suggest that the correlation exists solely in those relapses regarding younger MS patients. There was no association detected between 25-hydroxy Vitamin D status and disability or disability progression during the three-year follow-up. Although, researchers did note that most patients were on low-dose supplements of the vitamin, leading to a second hypothesis advanced by the researching team. This was that higher dosages of Vitamin D could have a possibility of preventing disability progression in MS patients. This is a study that should be tested in a future follow up study.